UNDER ARMOUR, INC. (UAA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $6.75, UNDER ARMOUR, INC. (UAA) is priced for +17.0% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/UAA

Headline

FieldValue
TickerUAA
CompanyUNDER ARMOUR, INC.
Current price$6.75/sh
CompositionApparel 68% / Footwear 22% / Accessories 8% / License revenues 2% / Corporate Other -1%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)3.5%
Operating margin (mid-cycle)4.5%
Margin compression (value-band)-1.0pp
Trailing margin (depressed year)-3.3%
Implied growth17.0%
Multiple paid20x mid-cycle operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 9.2% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~7pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.65σ
sustained it ~5 years at this level42%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple; asset-based/growth-DCF land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.14x2expensive
Earnings0
Relative0.29x2justifies
Growth1.78x1expensive

Families that justify the price: Relative Families that call it expensive: Asset, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.1%); the inversion above states its own rate.

Per-Model Detail (n=5)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noNegative/zero FCF — equity value floored at $0
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$23.380.29xyesP/S fallback (negative EPS): Sector P/S 2.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$3.332.03xyesReference only (book value floor): BV/sh $3.33, ROE negative
Two-Stage Excess ReturnAsset$3.002.25xyesReference only (book value with convergence): BV/sh $3.33, ROE converges to ke
Discounted Future Market CapGrowth$3.791.78xyesRev $5.0B, growth -4% (input: historical growth; tapered), Terminal P/S: 0.5x / 0.6x / 0.7x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$0.01675.00xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.10B × (1−21%) / WACC 5.1% → EPV (no growth) (excluded from median)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelative$0.01675.00xyesEBITDA $0.09B × sector EV/EBITDA 14.0x (excluded from median)
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$23.380.29xyesRevenue $4.97B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$881.3m
Net debt / NOPAT (after-tax)5.03x
Net debt / operating income (pre-tax)3.97x
Interest coverage4.2x
Share count CAGR (buyback)-3.0%
Burning cashyes

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 4.5%); the trailing year was depressed.

Bullet Takeaways

Bull Case

The balance sheet is where the turnaround case has to start, because it is what buys the brand the time to fix itself. Under Armour carries gross debt of about $1.19 billion against roughly $309 million in liquid assets, leaving net debt near $881 million, and trailing operating income is still negative as restructuring works through the numbers. The company has booked $261 million in total restructuring and transformation costs to date, $109 million in cash and $152 million in non-cash charges. Interest coverage near four times says the debt is serviceable through the reset, and the share count has actually been shrinking, down about 3% a year, rather than the dilution a distressed retailer usually resorts to. Management is funding the fix from the business, not the equity market.

The brand itself is the asset the balance sheet is protecting. Under Armour's 10-K describes products "worn by athletes at all levels, from youth to professional, on playing fields around the globe and by consumers with active lifestyles", and frames the strategy plainly as "driving premium brand-right growth and delivering improved profitability". That is the whole thesis in the company's own words: stop chasing volume at discount, rebuild margin on a premium positioning. The same filing names why it believes it competes, citing "our brand image and recognition, the performance and quality of our products and our selective distribution", the last phrase signaling the deliberate pullback from over-distribution that diluted the brand.

The operational evidence is starting to line up behind the words. CEO Kevin Plank described fiscal 2026 as reflecting "intentional steps we're taking to reset the business and restore the discipline required to operate as a best-in-class brand", and the company pointed to wholesale relationships stabilizing, with partners shifting from cancellations toward reorder consistency. Adjusted diluted EPS of $0.12 for the year is thin, but for a brand the relative-multiple lens already prices at a quarter of where a healthy apparel peer would trade, the bet is that stabilization is the floor and fiscal 2027 is where growth resumes.

Bear Case

The variable with the most leverage on this turnaround sits outside management's control: the cost of importing what Under Armour sells. An apparel and footwear company that sources globally lives and dies on landed cost, and the price near $6 does not obviously reflect how a tariff or trade-policy shift would land on a brand already fighting to rebuild gross margin. The 10-K is direct that economic disruption in key markets "may materially harm our sales, profitability and financial condition and our prospects for growth", and that the industry faces "significant pricing pressure" from many directions. For a company whose entire reset depends on charging more, not less, an external cost shock that forces discounting would strike at the exact lever the turnaround needs.

The margin math is already strained before any external shock. Gross profit fell $155.5 million to $2.5 billion in fiscal 2025, per the filing, even as the company spent to ship and operate its distribution network. The reset is real, but it is being paid for in the present: trailing operating income is negative, and the $261 million of restructuring charges is cash and book value leaving the company while revenue stabilizes rather than grows. A turnaround that is still consuming charges, two years in, is one where the timeline to durable profit keeps extending, and the price assumes that timeline holds.

Competition is the slow pressure underneath all of it. Under Armour's own filing concedes that when retailers "earn higher margins from our competitors' products or their own private label offerings, they may favor the display and sale of those products", an honest admission that shelf space is not guaranteed. Against far larger athletic brands with deeper marketing budgets and the rise of private label, Under Armour is fighting for relevance from a weakened position. The price implies the brand reaches roughly mid-single-digit operating margins and grows the top line low double digits; both require winning back a consumer and a wholesale channel that have plenty of alternatives, and the bear case is simply that the reset stabilizes the brand without restoring the growth the price still pays for.

Valuation

The price tells a turnaround story, and the methods we use to triangulate split on whether to believe it. The relative-multiple lens, valuing Under Armour against apparel peers, lands well above the price, treating the stock as cheap at roughly a quarter of where a healthy comparable would trade. The methods grounded in current economics disagree. With trailing operating income negative, the earnings-power and growth-cash-flow approaches either cannot anchor on a real base or land below the price, and the book-value-plus-profitability methods sit modestly under it. The pattern is the classic deep-value-or-trap setup: the sector multiple says bargain, the company's own profitability says the business has to earn that multiple back first.

What the price actually requires is mid-single-digit operating margins and low-double-digit growth, against a company running a small negative margin today. That is a recovery, not a fantasy, which is why the priced-in assumption reads as within range rather than stretched. The bet is one of execution and timeline: the margins are reachable for this brand at its prior scale, but they have to be reached while restructuring charges still run and while wholesale and consumer demand stabilize. The relative-multiple support is real only if the recovery arrives.

Solvency is the binding constraint here, and it deserves the close. Net debt of about $881 million against negative operating income would be alarming except that interest coverage sits near four times and liquid assets of roughly $309 million plus a shrinking share count give the company room. The balance sheet can carry a turnaround; what it cannot carry is an indefinite one. The price is underwriting a brand reset that converts to profit on a fiscal 2027 timeline, and the debt load is the clock running against it.

Catalysts

The fiscal 2026 year, reported May 12, 2026 for the period ended March 31, framed the reset as on track if unspectacular. Adjusted diluted EPS came in at $0.12, and management emphasized operational milestones over headline growth. CEO Kevin Plank described the year as reflecting intentional steps to reset the business, pointing to a streamlined operating model and increased accountability driving what he called a more controlled and predictable business.

The most concrete progress was in the wholesale channel. The company confirmed a shift away from high return rates and order cancellations toward greater reorder consistency, and underscored confidence in returning both North America and APAC to stability and potential growth by fiscal 2027, based on channel, product, and operating milestones. The $261 million of cumulative restructuring and transformation costs marks how much has been spent to get there.

The catalysts ahead are the fiscal 2027 proof points: whether North America stops shrinking and whether the premium repositioning shows up as gross-margin recovery rather than promotional give-back. Those two readings, more than any single quarter's EPS, are what decide whether the brand reset converts into the growth the price is already paying for.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

UA fiscal 2026 Q4 results, May 12 2026

View the full interactive UAA report on boothcheck